AAAAAA
Results: 51-75/102
Authors:
Nishida, T
Matsuno, H
Kozawa, O
Ueshima, S
Matsuo, O
Collen, D
Uematsu, T
Citation: T. Nishida et al., tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitor, J CARDIO PH, 36(6), 2000, pp. 770-775
Authors:
Collen, D
Sobel, B
Citation: D. Collen et B. Sobel, Intracranial haemorrhage with bolus thrombolytic agents, LANCET, 356(9244), 2000, pp. 1848-1848
Authors:
Carmeliet, P
Collen, D
Citation: P. Carmeliet et D. Collen, Transgenic mouse models in angiogenesis and cardiovascular disease, J PATHOLOGY, 190(3), 2000, pp. 387-405
Authors:
Chan, JCY
Cornelissen, I
Collen, D
Ploplis, VA
Castellino, FJ
Citation: Jcy. Chan et al., Combined factor VII/protein C deficiency results in intrauterine coagulopathy in mice, J CLIN INV, 105(7), 2000, pp. 897-903
Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3)
Authors:
Lijnen, HR
Arza, B
Van Hoef, B
Collen, D
Declerck, PJ
Citation: Hr. Lijnen et al., Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3), J BIOL CHEM, 275(48), 2000, pp. 37645-37650
Authors:
Baes, M
Huyghe, S
Carmeliet, P
Declercq, PE
Collen, D
Mannaerts, GP
Van Veldhoven, PP
Citation: M. Baes et al., Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids, J BIOL CHEM, 275(21), 2000, pp. 16329-16336
Authors:
Arza, B
Hoylaerts, MF
Felez, J
Collen, D
Lijnen, HR
Citation: B. Arza et al., Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue-type plasminogen activator, EUR J BIOCH, 267(21), 2000, pp. 6378-6384
Authors:
Budts, W
Pokreisz, P
Nong, ZX
Van Pelt, N
Gillijns, H
Gerard, R
Lyons, R
Collen, D
Bloch, KD
Janssens, S
Citation: W. Budts et al., Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxicpulmonary hypertension and pulmonary vascular remodeling in rats, CIRCULATION, 102(23), 2000, pp. 2880-2885
Authors:
Collen, D
Sinnaeve, P
Demarsin, E
Moreau, H
De Maeyer, M
Jespers, L
Laroche, Y
Van de Werf, F
Citation: D. Collen et al., Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction, CIRCULATION, 102(15), 2000, pp. 1766-1772
Authors:
Matsuno, H
Kozawa, O
Ueshima, S
Matsuo, O
Collen, D
Uematsu, T
Citation: H. Matsuno et al., The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice, BR J PHARM, 131(4), 2000, pp. 858
Authors:
Laroche, Y
Heymans, S
Capaert, S
De Cock, F
Demarsin, E
Collen, D
Citation: Y. Laroche et al., Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopes, BLOOD, 96(4), 2000, pp. 1425-1432
Authors:
Conway, EM
Collen, D
Schuh, A
Citation: Em. Conway et al., Evidence that survivin inhibit caspase-3 activity, BLOOD, 96(12), 2000, pp. 4003-4003
Authors:
Conway, EM
Pollefeyt, S
Cornelissen, J
DeBaere, I
Steiner-Mosonyi, M
Ong, K
Baens, M
Collen, D
Schuh, AC
Citation: Em. Conway et al., Three differentially expressed survivin cDNA variants encode proteins withdistinct antiapoptotic functions, BLOOD, 95(4), 2000, pp. 1435-1442
Authors:
Vanwetswinkel, S
Plaisance, S
Zhang, ZY
Vanlinthout, I
Brepoels, K
Lasters, I
Collen, D
Jespers, L
Citation: S. Vanwetswinkel et al., Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinase, BLOOD, 95(3), 2000, pp. 936-942
Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from anovel Chryseobacterium sp.
Authors:
Lijnen, HR
Van Hoef, B
Ugwu, F
Collen, D
Roelants, I
Citation: Hr. Lijnen et al., Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from anovel Chryseobacterium sp., BIOCHEM, 39(2), 2000, pp. 479-488
Authors:
Creemers, E
Cleutjens, J
Smits, J
Heymans, S
Moons, L
Collen, D
Daemen, M
Carmeliet, P
Citation: E. Creemers et al., Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction, AM J PATH, 156(6), 2000, pp. 1865-1873
Authors:
Armstrong, PW
Burton, JR
Palisaitis, D
Thompson, CR
Van de Werf, F
Rose, B
Collen, D
Teo, KK
Citation: Pw. Armstrong et al., Collaborative Angiographic Patency Trial of Recombinant Staphylokinase (CAPTORS), AM HEART J, 139(5), 2000, pp. 820-823
Authors:
Merchiers, P
De Vriese, A
Bulens, F
Collen, D
Belayew, A
Citation: P. Merchiers et al., Thyroid hormone inhibits transcription of the human tissue type plasminogen activator gene promoter, FIBRINOL PR, 13(3), 1999, pp. 104-112
Authors:
Plow, EF
Ploplis, VA
Carmeliet, P
Collen, D
Citation: Ef. Plow et al., Plasminogen and cell migration in vivo, FIBRINOL PR, 13(2), 1999, pp. 49-53
Authors:
Lijnen, HR
Van Hoef, B
Vanlinthout, I
Verstreken, M
Rio, MC
Collen, D
Citation: Hr. Lijnen et al., Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation, ART THROM V, 19(12), 1999, pp. 2863-2870
Authors:
Carmeliet, P
Ng, YS
Nuyens, D
Theilmeier, G
Brusselmans, K
Cornelissen, I
Ehler, E
Kakkar, VV
Stalmans, I
Mattot, V
Perriard, JC
Dewerchin, M
Flameng, W
Nagy, A
Lupu, F
Moons, L
Collen, D
D'Amore, PA
Shima, DT
Citation: P. Carmeliet et al., Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188), NAT MED, 5(5), 1999, pp. 495-502
Authors:
Heymans, S
Luttun, A
Nuyens, D
Theilmeier, G
Creemers, E
Moons, L
Dyspersin, GD
Cleutjens, JPM
Shipley, M
Angellilo, A
Levi, M
Nube, O
Baker, A
Keshet, E
Lupu, F
Herbert, JM
Smits, JFM
Shapiro, SD
Baes, M
Borgers, M
Collen, D
Daemen, MJAP
Carmeliet, P
Citation: S. Heymans et al., Inhibition of plasminogen activators or matrix metalloproteinases preventscardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure, NAT MED, 5(10), 1999, pp. 1135-1142
Authors:
Varenne, O
Gerard, RD
Sinnaeve, P
Gillijns, H
Collen, D
Janssens, S
Citation: O. Varenne et al., Percutaneous adenoviral gene transfer into porcine coronary arteries: Is catheter-based gene delivery adapted to coronary circulation?, HUM GENE TH, 10(7), 1999, pp. 1105-1115
Authors:
Praus, M
Wauterickx, K
Collen, D
Gerard, RD
Citation: M. Praus et al., Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors, GENE THER, 6(2), 1999, pp. 227-236
Authors:
Rabijns, A
De Bondt, HL
Collen, D
De Ranter, C
Citation: A. Rabijns et al., A fully functional deletion staphylokinase derivative crystallizes in two non-isomorphous monoclinic modifications, ACT CRYST D, 55, 1999, pp. 709-711